New Jersey

Palatin Technologies, Inc. Initiates Subject Dosing in First-in-Human Clinical Study of PL-8177, an Investigational Melanocortin Receptor 1 Agonist

CRANBURY, , Feb. 5, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical…
Continue Reading »
New Jersey

Amneal Launches Methylphenidate Hydrochloride Extended-Release Tablets, USP (CII) AB-Rated Generic for Concerta®

BRIDGEWATER, , Feb. 5, 2018 /PRNewswire/ -- Amneal Pharmaceuticals has launched methylphenidate hydrochloride extended-release tablets, USP (CII) in 18, 27, 36, and 54 mg strengths. Amneal's methylphenidate is an AB-rated equivalent…
Continue Reading »
New Jersey

BrainStorm Cell Therapeutics Appoints Senior Kite Executive, Anthony Polverino, Ph.D., to Board of Directors

HACKENSACK, and PETACH TIKVAH, Israel, Feb. 5, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today the…
Continue Reading »
New Jersey

New Robo Report™ Offers 2 Year Performance Numbers for 7 Top Robo Advisors In New Q4 2017 Report; Publisher BackEnd Benchmarking Interviews Robo Advisors

MARTINSVILLE, , Feb. 2, 2018 /PRNewswire/ -- The 6th Edition of The Robo Report™, the first and only report on the performance and portfolios of robo advisors in the digital advice…
Continue Reading »
New Jersey

Selective Reports Strong Results for the Fourth Quarter of 2017 – Net Income per Diluted Share of $0.51; Non-GAAP Operating Income(1) per Diluted Share of $0.86; and Superior Full Year 2017 Results with an ROE of 10.4% and Non-GAAP Operating ROE(1) of 11.4%

BRANCHVILLE, , Feb. 1, 2018 /PRNewswire/ --   In the fourth quarter of 2017: Net premiums written grew 8% GAAP combined ratio was Statutory combined ratio was After-tax net investment income was…
Continue Reading »
New Jersey

Covanta Holding Corporation Fourth Quarter And Full Year 2017 Earnings Conference Call To Be Held On February 23, 2018

MORRISTOWN, , Feb. 1, 2018 /PRNewswire/ -- Covanta Holding Corporation (NYSE: CVA) ("Covanta" or the "Company") will host a conference call at 8:30 AM (Eastern) on Friday, February 23, 2018 to…
Continue Reading »